Unicycive Therapeutics is a clinical-stage biotechnology company focused on developing therapies for kidney disease. Founded in 2016, it has two product candidates: oxylanthanum carbonate (OLC), a next-generation phosphate binder for hyperphosphatemia in CKD dialysis patients, and UNI-494, a novel drug for acute kidney injury. The company licenses technologies and pursues FDA approval via the 505(b)(2) pathway, with plans to partner globally for commercialization outside the U.S.
Q2 FY2026 — expected 2026-08-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001213900-26-035903 | EDGAR | 80K words |
| 2025-03-31 | 2024-12-31 | 0001213900-25-025828 | EDGAR | 80K words |
| 2024-03-28 | 2023-12-31 | 0001213900-24-027202 | EDGAR | 73K words |
| 2023-03-31 | 2022-12-31 | 0001213900-23-024901 | EDGAR | 67K words |
| 2022-03-31 | 2021-12-31 | 0001213900-22-016384 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001213900-26-088013 | EDGAR | 31K words |
| 2025-11-12 | 2025-09-30 | 0001213900-25-108600 | EDGAR | 30K words |
| 2025-08-14 | 2025-06-30 | 0001213900-25-076007 | EDGAR | 29K words |
| 2025-05-14 | 2025-03-31 | 0001213900-25-042943 | EDGAR | 26K words |
| 2024-11-13 | 2024-09-30 | 0001213900-24-097118 | EDGAR | 31K words |
| 2024-08-14 | 2024-06-30 | 0001213900-24-068565 | EDGAR | 29K words |
| 2024-05-13 | 2024-03-31 | 0001213900-24-042298 | EDGAR | 27K words |
| 2023-11-14 | 2023-09-30 | 0001213900-23-086979 | EDGAR | 27K words |
| 2023-08-14 | 2023-06-30 | 0001213900-23-067230 | EDGAR | 26K words |
| 2023-05-16 | 2023-03-31 | 0001213900-23-040161 | EDGAR | 24K words |
| 2022-11-14 | 2022-09-30 | 0001213900-22-071557 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001213900-22-048198 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-28 | 0001213900-26-104076 | EDGAR | 1K words |
| 2026-08-12 | 0001213900-26-088061 | EDGAR | 2K words |
| 2026-04-06 | 0001213900-26-040179 | EDGAR | 0K words |
| 2026-03-30 | 0001213900-26-035961 | EDGAR | 2K words |
| 2025-11-14 | 0001213900-25-111045 | EDGAR | 1K words |
| 2025-11-12 | 0001213900-25-108847 | EDGAR | 2K words |
| 2025-10-28 | 0001213900-25-102790 | EDGAR | 1K words |
| 2025-08-18 | 0001213900-25-077937 | EDGAR | 1K words |
| 2025-08-15 | 0001213900-25-077497 | EDGAR | 0K words |
| 2025-08-14 | 0001213900-25-076066 | EDGAR | 2K words |
102 total filings indexed. 75 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001766140 |
| Ticker | UNCY |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.unicycive.com |
| Listed | 2021-07-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/UNCY (~200 tokens, structured JSON with cryptographic provenance)